Topic - Margaret A. Hamburg

Subscribe to this topic via RSS or ATOM
Related Stories
  • FDA chief defends Zohydro as criticism intensifies

    Debate over a powerful new painkiller ratcheted up Thursday as the head of the Food and Drug Administration defended the drug's approval and a West Virginia Senator responded with a bill to force it off the market.

  • FDA to boost India staff overseeing drug imports

    The head of the Food and Drug Administration said Friday that her agency will add more inspectors in India to better monitor drugs from the country's burgeoning pharmaceutical industry, even as her agency also seeks closer cooperation from Indian regulators.

  • ** FILE ** In this March 8, 2010, file photo, the sandwich board at the Panera store in Brookline, Mass., shows the calorie count for each item. Diners will have to wait a little longer to find calorie counts on most restaurant chain menus, in supermarkets and on vending machines. (AP Photo/Charles Krupa, File)

    FDA head says menu labeling 'thorny' issue

    Diners will have to wait a little longer to find calorie counts on most restaurant chain menus, in supermarkets and on vending machines.

  • FDA head says menu labeling 'thorny' issue

    Diners will have to wait a little longer to find calorie counts on most restaurant chain menus, in supermarkets and on vending machines.

  • FDA seeks more authority amid meningitis outbreak

    The head of the Food and Drug Administration asked Congress Wednesday for more authority to police pharmacies like the one that triggered a deadly meningitis outbreak, even as lawmakers questioned why the agency didn't do more with its existing powers.

  • FDA warning public of risks of online pharmacies

    The Food and Drug Administration is warning U.S. consumers that the vast majority of Internet pharmacies are fraudulent and likely are selling counterfeit drugs that could harm them.

  • FDA urged to set standards for arsenic in rice

    The Food and Drug Administration may consider new standards for the levels of arsenic in rice as consumer groups are calling for federal guidance on how much of the carcinogen can be present in food.

  • FDA: New suppliers to ease 2 cancer drug shortages

    Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages _ at least for the time being _ that have left patients and parents frightened about missing life-saving treatments.

  • Shortage of 2 cancer drugs met by new suppliers

    Federal regulators have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been ratcheting up fears that patients, particularly children with leukemia, would miss lifesaving treatments.

  • FDA: New suppliers to ease 2 cancer drug shortages

    Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages _ at least for the time being _ that have left patients and parents frightened about missing life-saving treatments.

  • ** FILE ** Dr. Margaret Hamburg is commissioner of the Food and Drug Administration. (AP Photo/J. Scott Applewhite, File)

    FDA: New suppliers to ease cancer drug shortages

    Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages — at least for the time being — that have left patients and parents frightened about missing life-saving treatments.

  • FDA revokes approval of Avastin for breast cancer

    The government delivered a blow to some desperate patients Friday as it ruled the blockbuster drug Avastin should no longer be used to treat advanced breast cancer.

  • California-based Genentech, Inc., makes the cancer drug Avastin. A new analysis raises fresh questions about the effectiveness and risks of Avastin. (Associated Press)

    FDA nixes approval of Avastin for breast cancer

    The Food and Drug Administration has revoked Avastin as treatment for breast cancer, citing evidence that the controversial drug carries serious side-effects without offering demonstrable benefits.

  • FDA revokes approval of Avastin for breast cancer

    The government delivered a blow to some desperate patients Friday as it ruled the blockbuster drug Avastin should no longer be used to treat advanced breast cancer.

  • Illustration: The pill

    GIROUX: Giving a pass to the pill

    Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg says "some very explicit, almost gruesome pictures may be necessary" on cigarette labels. The FDA is concerned about serious medical consequences of smoking, such as cancer, heart disease and strokes - and for good reason. Cigarettes have proved deadly. The images are part of a new campaign launched by the FDA and the Department of Health and Human Services in response to the 443,000 deaths per year caused by cigarette smoking.

More Stories →

Quotations
Happening Now